SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-28
👔
Elanco Animal Health Inc
@ELAN_InsiderForm 4 Filing: Simmons Jeffrey N Acquires (Grant) shares of $ELAN
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
Elanco Animal Health Inc
Ticker: $ELAN
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-24
Shares: 113.486
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Simmons Jeffrey N, holds the title of PRESIDENT, CEO AND DIRECTOR at Elanco Animal Health Inc.
On 2026-07-24, the insider transacted 113.486 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Simmons Jeffrey N (PRESIDENT, CEO AND DIRECTOR) was granted $0 of $ELAN
Post-Transaction Position: 24,884.388 shares
SEC Accession No: 0001479079-26-000035 (CIK: 1479079)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.